Elena Mazzone

10.3k total citations
43 papers, 1.3k citations indexed

About

Elena Mazzone is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Elena Mazzone has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 17 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Elena Mazzone's work include Neurogenetic and Muscular Disorders Research (29 papers), Muscle Physiology and Disorders (11 papers) and Congenital Anomalies and Fetal Surgery (7 papers). Elena Mazzone is often cited by papers focused on Neurogenetic and Muscular Disorders Research (29 papers), Muscle Physiology and Disorders (11 papers) and Congenital Anomalies and Fetal Surgery (7 papers). Elena Mazzone collaborates with scholars based in Italy, United States and United Kingdom. Elena Mazzone's co-authors include Eugenio Mercuri, Marika Pane, Marion Main, Richard S. Finkel, Allan M. Glanzman, Sonia Messina, Alessandra Solari, Lucía Morandi, Luciano Merlini and Enrico Bertini and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Elena Mazzone

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Mazzone Italy 19 847 721 506 272 130 43 1.3k
Bart Bartels Netherlands 21 707 0.8× 424 0.6× 456 0.9× 209 0.8× 154 1.2× 44 1.2k
Marion Main United Kingdom 20 1.4k 1.7× 1.3k 1.9× 829 1.6× 358 1.3× 201 1.5× 41 2.3k
Allan M. Glanzman United States 20 1.4k 1.6× 1.1k 1.5× 828 1.6× 323 1.2× 331 2.5× 60 2.1k
Anna‐Karin Kroksmark Sweden 19 528 0.6× 695 1.0× 186 0.4× 140 0.5× 201 1.5× 39 1.2k
Sally Dunaway Young United States 22 1.2k 1.4× 676 0.9× 746 1.5× 215 0.8× 168 1.3× 68 1.5k
Tina Duong United States 14 316 0.4× 691 1.0× 155 0.3× 228 0.8× 84 0.6× 60 945
Anna Mayhew United Kingdom 20 392 0.5× 982 1.4× 156 0.3× 377 1.4× 195 1.5× 61 1.4k
Amy Pasternak United States 14 379 0.4× 302 0.4× 238 0.5× 223 0.8× 72 0.6× 30 710
Giorgia Coratti Italy 18 627 0.7× 426 0.6× 412 0.8× 121 0.4× 51 0.4× 53 822
Kristin J. Krosschell United States 15 742 0.9× 456 0.6× 385 0.8× 110 0.4× 230 1.8× 32 1.0k

Countries citing papers authored by Elena Mazzone

Since Specialization
Citations

This map shows the geographic impact of Elena Mazzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Mazzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Mazzone more than expected).

Fields of papers citing papers by Elena Mazzone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Mazzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Mazzone. The network helps show where Elena Mazzone may publish in the future.

Co-authorship network of co-authors of Elena Mazzone

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Mazzone. A scholar is included among the top collaborators of Elena Mazzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Mazzone. Elena Mazzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, Thomas O., John Day, Darryl C. De Vivo, et al.. (2024). Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study. Frontiers in Neurology. 15. 1419791–1419791. 5 indexed citations
2.
Oskoui, Maryam, Nicolas Deconinck, Elena Mazzone, et al.. (2023). Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA). Journal of the Neurological Sciences. 455. 121096–121096. 2 indexed citations
3.
Duong, Tina, Kristin J. Krosschell, M. James, et al.. (2021). Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases. Frontiers in Genetics. 12. 735936–735936. 4 indexed citations
4.
Oskoui, Maryam, John Day, Nicolas Deconinck, et al.. (2021). SUNFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Patients with Type 2 or Non-ambulant Type 3 Spinal Muscular Atrophy (SMA) (2240). Neurology. 96(15_supplement). 2 indexed citations
5.
Montes, Jacqueline, Sally Dunaway Young, Elena Mazzone, et al.. (2018). Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. (P2.322). Neurology. 90(15_supplement). 4 indexed citations
6.
Kirschner, Janbernd, Eugenio Mercuri, Richard S. Finkel, et al.. (2017). Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study. Neuropediatrics. 48.
7.
Sanctis, Roberto De, Marika Pane, Giorgia Coratti, et al.. (2017). Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy. Neuromuscular Disorders. 28(1). 24–28. 38 indexed citations
8.
Glanzman, Allan M., Elena Mazzone, Sally Dunaway Young, et al.. (2017). Reliability of functional outcome measures in spinal muscular atrophy: Results from multi-centered, global, phase 3 clinical trials (S13.004). Neurology. 88(16_supplement).
9.
Pera, Maria Carmela, Marco Luigetti, Marika Pane, et al.. (2017). 6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction. Neuromuscular Disorders. 27(10). 879–882. 41 indexed citations
10.
Sanctis, Roberto De, Giorgia Coratti, Amy Pasternak, et al.. (2016). Developmental milestones in type I spinal muscular atrophy. Neuromuscular Disorders. 26(11). 754–759. 90 indexed citations
11.
Mercuri, Eugenio, Giorgia Coratti, Sonia Messina, et al.. (2016). Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy. PLoS ONE. 11(8). e0160195–e0160195. 39 indexed citations
12.
Pera, Maria Carmela, Domenico M. Romeo, Alessandra Graziano, et al.. (2016). Sleep disorders in spinal muscular atrophy. Sleep Medicine. 30. 160–163. 21 indexed citations
13.
Montes, Jacqueline, Allan M. Glanzman, Elena Mazzone, et al.. (2015). Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy. Muscle & Nerve. 52(6). 942–947. 18 indexed citations
14.
Sivo, Serena, Elena Mazzone, Laura Antonaci, et al.. (2014). Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscular Disorders. 25(3). 212–215. 23 indexed citations
15.
Mazzone, Elena, Gessica Vasco, Concetta Palermo, et al.. (2012). A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. 54(10). 879–885. 53 indexed citations
16.
Mercuri, Eugenio, Craig M. McDonald, Anna Mayhew, et al.. (2012). International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy. Neuromuscular Disorders. 22(11). 1025–1028. 21 indexed citations
17.
Mercuri, Eugenio & Elena Mazzone. (2010). Choosing the right clinical outcome measure: From the patient to the statistician and back. Neuromuscular Disorders. 21(1). 16–19. 13 indexed citations
18.
Glanzman, Allan M., Elena Mazzone, Marion Main, et al.. (2010). The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. Neuromuscular Disorders. 20(3). 155–161. 230 indexed citations
19.
Pane, Marika, Susanna Staccioli, Sonia Messina, et al.. (2008). Daily salbutamol in young patients with SMA type II. Neuromuscular Disorders. 18(7). 536–540. 80 indexed citations
20.
Merlini, Luciano, Elena Mazzone, Alessandra Solari, & Lucía Morandi. (2002). Reliability of hand‐held dynamometry in spinal muscular atrophy. Muscle & Nerve. 26(1). 64–70. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bart Bartels Breakdown of academic impact, for papers by Marion Main Breakdown of academic impact, for papers by Allan M. Glanzman Breakdown of academic impact, for papers by Anna‐Karin Kroksmark Breakdown of academic impact, for papers by Sally Dunaway Young Breakdown of academic impact, for papers by Tina Duong Breakdown of academic impact, for papers by Anna Mayhew Breakdown of academic impact, for papers by Amy Pasternak Breakdown of academic impact, for papers by Giorgia Coratti Breakdown of academic impact, for papers by Kristin J. Krosschell
Rankless by CCL
2026